These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24684906)

  • 21. Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis.
    Li M; Kandror O; Akopian T; Dharkar P; Wlodawer A; Maurizi MR; Goldberg AL
    J Biol Chem; 2016 Apr; 291(14):7465-76. PubMed ID: 26858247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An efficient synthetic route for preparation of antimycobacterial wollamides and evaluation of their in vitro and in vivo efficacy.
    Asfaw H; Wetzlar T; Martinez-Martinez MS; Imming P
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2899-2905. PubMed ID: 30031620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial Activity.
    Akopian T; Kandror O; Tsu C; Lai JH; Wu W; Liu Y; Zhao P; Park A; Wolf L; Dick LR; Rubin EJ; Bachovchin W; Goldberg AL
    J Biol Chem; 2015 Apr; 290(17):11008-20. PubMed ID: 25759383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1.
    Leodolter J; Warweg J; Weber-Ban E
    PLoS One; 2015; 10(5):e0125345. PubMed ID: 25933022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and characterization of a novel C-terminal peptide carboxyl methyltransferase in a lassomycin-like lasso peptide biosynthetic pathway.
    Su Y; Han M; Meng X; Feng Y; Luo S; Yu C; Zheng G; Zhu S
    Appl Microbiol Biotechnol; 2019 Mar; 103(6):2649-2664. PubMed ID: 30707253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease.
    Famulla K; Sass P; Malik I; Akopian T; Kandror O; Alber M; Hinzen B; Ruebsamen-Schaeff H; Kalscheuer R; Goldberg AL; Brötz-Oesterhelt H
    Mol Microbiol; 2016 Jul; 101(2):194-209. PubMed ID: 26919556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome.
    Moreira W; Santhanakrishnan S; Ngan GJY; Low CB; Sangthongpitag K; Poulsen A; Dymock BW; Dick T
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193668
    [No Abstract]   [Full Text] [Related]  

  • 28. Peptide AS-48: prototype of a new class of cyclic bacteriocins.
    Maqueda M; Gálvez A; Bueno MM; Sanchez-Barrena MJ; González C; Albert A; Rico M; Valdivia E
    Curr Protein Pept Sci; 2004 Oct; 5(5):399-416. PubMed ID: 15544535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lys17 in the 'lasso' peptide lariatin A is responsible for anti-mycobacterial activity.
    Iwatsuki M; Koizumi Y; Gouda H; Hirono S; Tomoda H; Omura S
    Bioorg Med Chem Lett; 2009 May; 19(10):2888-90. PubMed ID: 19362475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nocardithiocin, a novel thiopeptide antibiotic, produced by pathogenic Nocardia pseudobrasiliensis IFM 0757.
    Mukai A; Fukai T; Hoshino Y; Yazawa K; Harada K; Mikami Y
    J Antibiot (Tokyo); 2009 Nov; 62(11):613-9. PubMed ID: 19745839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring.
    Akopian T; Kandror O; Raju RM; Unnikrishnan M; Rubin EJ; Goldberg AL
    EMBO J; 2012 Mar; 31(6):1529-41. PubMed ID: 22286948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and Biosynthesis of Gladiolin: A Burkholderia gladioli Antibiotic with Promising Activity against Mycobacterium tuberculosis.
    Song L; Jenner M; Masschelein J; Jones C; Bull MJ; Harris SR; Hartkoorn RC; Vocat A; Romero-Canelon I; Coupland P; Webster G; Dunn M; Weiser R; Paisey C; Cole ST; Parkhill J; Mahenthiralingam E; Challis GL
    J Am Chem Soc; 2017 Jun; 139(23):7974-7981. PubMed ID: 28528545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isolation, biological properties, and spatial structure of an antibiotic loloatin A].
    Krachkovskiĭ SA; Sobol' AG; Ovchinnikova TV; Tagaev AA; Iakimenko ZA; Azizbekian RR; Kuznetsova NI; Shamshina TN; Arsen'ev AS
    Bioorg Khim; 2002; 28(4):298-302. PubMed ID: 12197385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-Activity Relationships of Wollamide Cyclic Hexapeptides with Activity against Drug-Resistant and Intracellular
    Khalil ZG; Hill TA; De Leon Rodriguez LM; Lohman RJ; Hoang HN; Reiling N; Hillemann D; Brimble MA; Fairlie DP; Blumenthal A; Capon RJ
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Massetolides A-H, antimycobacterial cyclic depsipeptides produced by two pseudomonads isolated from marine habitats.
    Gerard J; Lloyd R; Barsby T; Haden P; Kelly MT; Andersen RJ
    J Nat Prod; 1997 Mar; 60(3):223-9. PubMed ID: 9157190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection.
    Tsantrizos YS; Bolger G; Bonneau P; Cameron DR; Goudreau N; Kukolj G; LaPlante SR; Llinàs-Brunet M; Nar H; Lamarre D
    Angew Chem Int Ed Engl; 2003 Mar; 42(12):1356-60. PubMed ID: 12671967
    [No Abstract]   [Full Text] [Related]  

  • 37. LspA-independent action of globomycin on Mycobacterium tuberculosis.
    Banaiee N; Jacobs WR; Ernst JD
    J Antimicrob Chemother; 2007 Aug; 60(2):414-6. PubMed ID: 17579235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial proteases, untapped antimicrobial drug targets.
    Culp E; Wright GD
    J Antibiot (Tokyo); 2017 Apr; 70(4):366-377. PubMed ID: 27899793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of the Cysteine Synthase CysM with Antibacterial Potency against Dormant Mycobacterium tuberculosis.
    Brunner K; Maric S; Reshma RS; Almqvist H; Seashore-Ludlow B; Gustavsson AL; Poyraz Ö; Yogeeswari P; Lundbäck T; Vallin M; Sriram D; Schnell R; Schneider G
    J Med Chem; 2016 Jul; 59(14):6848-59. PubMed ID: 27379713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of New Cyclomarin Derivatives and Their Biological Evaluation towards Mycobacterium Tuberculosis and Plasmodium Falciparum.
    Kiefer A; Bader CD; Held J; Esser A; Rybniker J; Empting M; Müller R; Kazmaier U
    Chemistry; 2019 Jul; 25(37):8894-8902. PubMed ID: 31012978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.